252
Views
34
CrossRef citations to date
0
Altmetric
Research Paper

Continuous stimulation with differentiation factors is necessary to enhance osteogenic differentiation of human mesenchymal stem cells in-vitro

, , , &
Pages 179-188 | Received 10 Jul 2017, Accepted 01 Nov 2017, Published online: 12 Dec 2017

References

  • Begam H, Nandi SK, Kundu B, Chanda A. 2017. Strategies for delivering bone morphogenetic protein for bone healing. Mater Sci Eng C Mater Biol Appl 70: 856–869.
  • Chen D, Zhao M, Mundy GR. 2004. Bone morphogenetic proteins. Growth Factors 22: 233–241.
  • Conway JD, Shabtai L, Bauernschub A, Specht SC. 2014. BMP-7 versus BMP-2 for the treatment of long bone nonunion. Orthopedics 37: e1049–e1057.
  • Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, et al. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315–317.
  • Fassbender M, Minkwitz S, Strobel C, Schmidmaier G, Wildemann B. 2014. Stimulation of bone healing by sustained bone morphogenetic protein 2 (BMP-2) delivery. Int J Mol Sci 15: 8539–8552.
  • Fischer C, Doll J, Tanner M, Bruckner T, Zimmermann G, Helbig L, Biglari B, et al. 2016. Quantification of TGF-ss1, PDGF and IGF-1 cytokine expression after fracture treatment vs. non-union therapy via masquelet. Injury 47: 342–349.
  • Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, Zych GA, et al. 2001. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83-A(Suppl 1): S151–S158.
  • Gautschi OP, Frey SP, Zellweger R. 2007. Bone morphogenetic proteins in clinical applications. ANZ J Surg 77: 626–631.
  • Giannoudis PV, Einhorn TA, Schmidmaier G, Marsh D. 2008. The diamond concept-open questions. Injury 39(Suppl 2): S5–S8.
  • Han D, Liu W, Ao Q, Wang G. 2008. Optimal delivery systems for bone morphogenetic proteins in orthopedic applications should model initial tissue repair structures by using a heparin-incorporated fibrin-fibronectin matrix. Med Hypotheses 71: 374–378.
  • Hoellig M, Westhauser F, Kornienko K, Xiao K, Schmidmaier G, Moghaddam A. 2016. Mesenchymal stem cells from reaming material possess high osteogenic potential and react sensitively to bone morphogenetic protein 7. J Appl Biomater Funct Mater 15: e54–e62.
  • Kanatani M, Sugimoto T, Kaji H, Kobayashi T, Nishiyama K, Fukase M, Kumegawa M, Chihara K. 1995. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity. J Bone Miner Res 10: 1681–1690.
  • Koch H, Jadlowiec JA, Campbell PG. 2005. Insulin-like growth factor-I induces early osteoblast gene expression in human mesenchymal stem cells. Stem Cells Dev 14: 621–631.
  • Krishnakumar GS, Roffi A, Reale D, Kon E, Filardo G. 2017. Clinical application of bone morphogenetic proteins for bone healing: A systematic review. Int Orthop 41: 1073–1083.
  • Kuehlfluck P, Moghaddam A, Helbig L, Child C, Wildemann B, Schmidmaier G, Group HT-HTR. 2015. RIA fractions contain mesenchymal stroma cells with high osteogenic potency. Injury 46(Suppl 8): S23–S32.
  • Laron Z. 2001. Insulin-like growth factor 1 (IGF-1): A growth hormone. Mol Pathol 54: 311–316.
  • Lee K, Silva EA, Mooney DJ. 2011. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface 8: 153–170.
  • Miska M, Findeisen S, Tanner M, Biglari B, Studier-Fischer S, Grutzner PA, Schmidmaier G, Moghaddam A. 2016. Treatment of nonunions in fractures of the humeral shaft according to the Diamond Concept. Bone Joint J 98-B: 81–87.
  • Okolicsanyi RK, Camilleri ET, Oikari LE, Yu C, Cool SM, van Wijnen AJ, Griffiths LR, Haupt LM. 2015. Human mesenchymal stem cells retain multilineage differentiation capacity including neural marker expression after extended in vitro expansion. PLoS One 10: e0137255.
  • Pietrzak WS, Ali SN, Chitturi D, Jacob M, Woodell-May JE. 2011. BMP depletion occurs during prolonged acid demineralization of bone: Characterization and implications for graft preparation. Cell Tissue Bank 12: 81–88.
  • Rath SN, Strobel LA, Arkudas A, Beier JP, Maier AK, Greil P, Horch RE, Kneser U. 2012. Osteoinduction and survival of osteoblasts and bone-marrow stromal cells in 3D biphasic calcium phosphate scaffolds under static and dynamic culture conditions. J Cell Mol Med 16: 2350–2361.
  • Sheng MH, Lau KH, Baylink DJ. 2014. Role of osteocyte-derived insulin-like growth factor I in developmental growth, modeling, remodeling, and regeneration of the bone. J Bone Metab 21: 41–54.
  • Vukicevic S, Basic V, Rogic D, Basic N, Shih MS, Shepard A, Jin D, et al. 1998. Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. J Clin Invest 102: 202–214.
  • Weiss S, Henle P, Bidlingmaier M, Moghaddam A, Kasten P, Zimmermann G. 2008. Systemic response of the GH/IGF-I axis in timely versus delayed fracture healing. Growth Horm IGF Res 18: 205–212.
  • Westhauser F, Hollig M, Reible B, Xiao K, Schmidmaier G, Moghaddam A. 2016a. Bone formation of human mesenchymal stem cells harvested from reaming debris is stimulated by low-dose bone morphogenetic protein-7 application in vivo. J Orthop 13: 404–408.
  • Westhauser F, Weis C, Hoellig M, Swing T, Schmidmaier G, Weber MA, Stiller W, et al. 2015. Heidelberg-mCT-Analyzer: A novel method for standardized microcomputed-tomography-guided evaluation of scaffold properties in bone and tissue research. R Soc Open Sci 2: 150496.
  • Westhauser F, Weis C, Prokscha M, Bittrich LA, Li W, Xiao K, Kneser U, et al. 2016b. Three-dimensional polymer coated 45S5-type bioactive glass scaffolds seeded with human mesenchymal stem cells show bone formation in vivo. J Mater Sci Mater Med 27: 119.
  • Wildemann B, Lange K, Strobel C, Fassbender M, Willie B, Schmidmaier G. 2011. Local BMP-2 application can rescue the delayed osteotomy healing in a rat model. Injury 42: 746–752.
  • Wozney JM. 2002. Overview of bone morphogenetic proteins. Spine 27: S2–S8.
  • Yakar S. 2002. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110: 771–781.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.